Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bioventus, ESS, and IBM and Encourages Investors to Contact the Firm

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bioventus, ESS, and IBM and Encourages Investors to Contact the Firm

Evercore ISI Removes IBM (IBM) from Tactical Outperform List

January 30, 2023 5:17 PM EST

Evercore ISI analyst Amit Daryanani reiterated an In Line rating and $150.00 price target on IBM (NYSE: IBM)

Removes from Tactical Outperform List.

For an analyst ratings summary and ratings history on IBM click here. For more ratings news on IBM click here.

Shares of IBM closed at $134.39 yesterday.

... More